<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00258141</url>
  </required_header>
  <id_info>
    <org_study_id>DM03RUP/IV/05</org_study_id>
    <nct_id>NCT00258141</nct_id>
  </id_info>
  <brief_title>Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects</brief_title>
  <official_title>A Placebo-Controlled, Double-Blind, Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>J. Uriach and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>J. Uriach and Company</source>
  <brief_summary>
    <textblock>
      The study will find out how effective rupatadine is in the treatment of mosquito bite
      symptoms in adult patients allergic to mosquito bites.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mosquito-bite symptoms include wheals and pruritic bite papules. Oral antihistamines have
      shown to decrease whealing ang accompanying pruritus in placebo-controlled trials.

      Subjects will be treated for 4 days, and exposed to experimental mosquito bite at day 3.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bite lesion size (squared mm)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pruritus on a Visual Analog Scale</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Allergy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rupatadine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recent history of suffering from mosquito-bite reactions.

          -  At least 5 mm diameter mosquito-bite wheal from Aedes aegypti laboratory mosquitoes

        Exclusion Criteria:

          -  Pregnancy or lactating females

          -  Oral antihistamines, corticosteroids or non-steroid anti-inflammatory drugs (NSAID)
             use within two weeks before the study.

          -  Severe or moderate systemic illness

          -  Allergy to rupatadine or other antihistamines

          -  Anaphylaxis from mosquito bites
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timo Reunala, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical School, University of Tampere and Tampere University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Timo Reunala, Prof.</last_name>
    <phone>(+358) 331165167</phone>
    <email>timo.reunala@uta.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ulappatorin Lääkäriasema</name>
      <address>
        <city>Espoo</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Leena Ackermann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Koskiklinikka, Tampere Lääkärikeskus</name>
      <address>
        <city>Tampere</city>
        <zip>33101</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ari Karppinen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>November 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2005</study_first_submitted>
  <study_first_submitted_qc>November 23, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2005</study_first_posted>
  <last_update_submitted>November 23, 2005</last_update_submitted>
  <last_update_submitted_qc>November 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2005</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyproheptadine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

